Westchester Biosciences Accelerator Welcomes New Corporate Partners
News Article Article pages that do not meet specifications for other Trust Project Type of Work labels and also do not fit within the general news category.
The Westchester County Biosciences Accelerator (WCBA), which supports the development of Westchester’s hub of life science innovation and commercialization, is pleased to welcome three new corporate partners: Boehringer Ingelheim, C3 Medical Device Consulting LLC and Moses Singer LLP.
Boehringer Ingelheim is one of the world’s leading research-driven pharmaceutical companies. C3 Medical Device Consulting LLC is a firm specializing in the development of next generation medical devices. Moses Singer LLP is a law firm with a health and technology practice that includes a specialization in cyber security for the medical field.
County Executive George Latimer said: “The Westchester County Biosciences Accelerator is a powerful program for catalyzing the growth of sector startups. We are proud to offer a robust program to support life science startups and have the support of corporate partners to enhance this endeavor.”
Westchester County’s Director of Entrepreneurship and Innovation, Deborah Novick, said: “We are thankful to the teams at Boehringer Ingelheim, C3 Medical Device Consulting LLC and Moses Singer LLP for their support and recognition of the importance of our accelerator program. Life science startups bring new, innovative thinking to the industry and we are proud to help them grow and prosper.”
WCBA Program Director and Principal of FirstXFounder, Mary Howard, said: “The Westchester County Biosciences Accelerator continues to attract inspiring entrepreneurs with transformative ideas. Our corporate partners play an important role in growing this vital program and we are proud to add Boehringer Ingelheim, C3 Medical Device Consulting LLC and Moses Singer LLP to that roster.”
The Westchester County Office of Economic Development (WCOED) created the WCBA in 2019 to develop a pipeline of early-stage life sciences ventures and add to the more than 8,000 jobs and diverse variety of life science employers already located in Westchester and the New York metro region. Through the WCBA’s competitive-entry six-month program, founders receive coaching, network connections and business mentorship. The program includes a pitch competition where members of the cohort present their venture business plans. In addition to the WCBA program, the WCOED houses an Industry Desk identifying the trends and needs of the life science community, as well as a Task Force to discuss issues within the local and regional ecosystem.
Boehringer Ingelheim, C3 Medical Device Consulting LLC and Moses Singer LLP join a roster of support for the WCBA, including: Atostek, JP Morgan Chase & Co, Pfizer and Wilson Sonsini.
This is a press release provided by the organization. It has been lightly edited and is being published by Examiner Media as a public service.
Examiner Media – Keeping you informed with professionally-reported local news, features, and sports coverage.
